SCHEMBL22633641

SCHEMBL22633641

NC(=S)NC1(CO)CC(F)(F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22633653 0.77
SCHEMBL24015502 0.71 SLC10A1 (0.31)
SCHEMBL22395868 0.70
SCHEMBL21843744 0.65
Hydrochloric Acid SCHEMBL19900818 0.62 APLNR (0.31)
SCHEMBL22395844 0.62 ALDH1A1 (0.31)
SCHEMBL22363155 0.60
SCHEMBL16914106 0.59
SCHEMBL22506477 0.58 APLNR (0.35)
SCHEMBL22395766 0.58 DGAT1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11267825-B2 Highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis B virus (HBV) AICURIS GMBH & CO. KG (DE) 2022-03-08 US disclosed
US-20220009945-A1 NOVEL UREA 6,7-DIHYDRO-4H-THIAZOLE[5,4-C]PYRIDINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) AICURIS GMBH & CO. KG (DE) 2022-01-13 US disclosed
CN-113039187-A Urea 6, 7-dihydro-4H-thiazolo [5,4-c ] pyridine active agents against hepatitis b virus HBV 艾库里斯有限及两合公司 2021-06-25 CN disclosed
US-20200354379-A1 NOVEL, HIGHLY ACTIVE AMINO-THIAZOLE SUBSTITUTED INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) AICURIS GMBH & CO. KG (DE) 2020-11-12 US disclosed
US-20200354379-A1 NOVEL, HIGHLY ACTIVE AMINO-THIAZOLE SUBSTITUTED INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) AICURIS GMBH & CO. KG (DE) 2020-11-12 US disclosed
CN-111448199-A Novel highly active amino-thiazole-substituted indole-2-carboxamides having activity against Hepatitis B Virus (HBV) 艾库里斯有限及两合公司 2020-07-24 CN disclosed